Our world-class team is comprised of experts in cancer biology, medicinal chemistry, next-generation chemical proteomics, computational chemistry and molecular biophysics, machine learning, and drug development.
About Us
Developing the next generation of targeted cancer therapies
Delivering superior precision medicines via the integration of advanced technologies and scientific excellence
Our fully integrated discovery platform is built upon the most advanced technologies available for drug discovery, small molecule design, and target identification that we believe will enable us to rapidly create highly selective small molecule compounds against an unprecedented spectrum of targets.
Our Vision
Transform the lives of cancer patients by pioneering the new era of
Precision Oncology 2.0™
Recognition
Leadership Team
Academic Founders
Board of Directors
Scientific Advisors
Investors
